Timothy Lopez

Ecteinascidin-743 (ET-743) for Chemotherapy-Naive Patients With Advanced Soft Tissue Sarcomas: Multicenter Phase II and Pharmacokinetic Study

Rocio García‐Carbonero, Jeffrey G. Supko, Robert G. Maki et al. · Journal of Clinical Oncology · 2005 · 191 citations · Full text

Medicine, Oncology, Pharmacology +11

Lack of Correlation between Epidermal Growth Factor Receptor Status and Response to Panitumumab Monotherapy in Metastatic Colorectal Cancer

J. Randolph Hecht, Edith P. Mitchell, Marcus A. Neubauer et al. · Clinical Cancer Research · 2010 · 108 citations

Medicine, Oncology, Pharmacology +17

Results of a Phase II Open-Label Study of Capecitabine in Combination with Irinotecan as First-Line Treatment for Metastatic Colorectal Cancer

Thomas H. Cartwright, Timothy Lopez, Svetislava J. Vukelja et al. · Clinical Colorectal Cancer · 2005 · 35 citations

Medicine, Oncology, Pharmacology +12

Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironment

Bassel Alsaed, Linh Lin, Jieun Son et al. · Nature Communications · 2025 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Oncogenic switch and single-agent MET inhibitor sensitivity in a subset of <i>EGFR</i> -mutant lung cancer

Pınar Ö. Eser, Raymond M. Paranal, Jieun Son et al. · Science Translational Medicine · 2021 · 18 citations · Full text

Medicine, Oncology, Pharmacology +15